The effect of Oncotype DX(®) on adjuvant chemotherapy treatment decisions in early breast cancer

INTRODUCTION: The aim of this study was to objectively establish the value of the Oncotype DX(®) (ODX) gene assay in adjuvant treatment decisions for intermediate risk patients with early, oestrogen receptor positive, human epidermal growth factor receptor 2 negative, lymph node negative breast canc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann R Coll Surg Engl
Egile Nagusiak: Rabie, MA, Rankin, A, Burger, A, Youssef, MMG
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Royal College of Surgeons 2019
Gaiak:
Breast Surgery
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6818070/
https://ncbi.nlm.nih.gov/pubmed/31219316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1308/rcsann.2019.0096
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak